Lafora disease is a rare, fatal genetic disorder affecting the brain, with limited treatment options and severe symptoms.

Here’s what experts know about NARS1 — the condition affecting Marley Mansour, a girl from North Texas — how it’s diagnosed, ...

Lupin has launched generic Tolvaptan tablets for kidney disorder treatment in the US, providing increased access to ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

Tolvaptan tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant ...

Mumbai: Global pharma major Lupin Limited has announced the launch of Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS acquisition.

Pharma major Lupin Ltd on Tuesday said it has launched the Tolvaptan tablets used to slow kidney function decline in the US ...

The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide.

Imbalances in metal ions may play a role in the development of diabetes and its complications. Can they be a novel target for ...